Acelrx Pharmaceuticals reported $7.14M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US USD 7.14M 7M
Baxter International BAX:US USD 6.57B 3.18B
Becton, Dickinson and BDX:US USD 4.27B 165M
Cara Therapeutics CARA:US USD 34.66M 7.18M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Intra Cellular Therapies ITCI:US USD 127.5M 16M
Johnson & Johnson JNJ:US USD 17.97B 211M
Pain Therapeutics PTIE:US USD 21.34M 1.43M
Pfizer PFE:US USD 13.23B 2.41B
Smiths SMIN:LN GBP 1.41B 379M
Teva Pharmaceutical TEVA:IT USD 3.18B 1.56B
Xeris Pharmaceuticals Inc XERS:US USD 48.5M 4.28M